Intl. congress on breast cancer researchJORDAN, V. C.Cancer letters. 1995, Vol 90, Num 1, issn 0304-3835, 109 p.Conference Proceedings

Epidemiology of breast cancer in JapanTOMINAGA, S; KUROISHI, T.Cancer letters. 1995, Vol 90, Num 1, pp 75-79, issn 0304-3835Conference Paper

Mutations in breast cancerCROPP, C. S.Cancer letters. 1995, Vol 90, Num 1, pp 51-56, issn 0304-3835Conference Paper

The etiopathogenesis of breast cancer preventionRUSSO, J; RUSSO, I. H.Cancer letters. 1995, Vol 90, Num 1, pp 81-89, issn 0304-3835Conference Paper

The immunogenicity of MUC1 peptides and fusion proteinAPOSTOLOPOULOS, V; PIETERSZ, G. A; XING, P.-X et al.Cancer letters. 1995, Vol 90, Num 1, pp 21-26, issn 0304-3835Conference Paper

Is episialin/MUC1 involved in breast cancer progression ?HILKENS, J; VOS, H. L; WESSELING, J et al.Cancer letters. 1995, Vol 90, Num 1, pp 27-33, issn 0304-3835Conference Paper

Comparative pathology of mammary tumorigenesis in transgenic miceCARDIFF, R. D; MUNN, R. J.Cancer letters. 1995, Vol 90, Num 1, pp 13-19, issn 0304-3835Conference Paper

Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancerDICKSON, C; FANTL, V; GILLETT, C et al.Cancer letters. 1995, Vol 90, Num 1, pp 43-50, issn 0304-3835Conference Paper

Controversies in the local management of invasive and non-invasive breast cancerPAGE, D. L; JOHNSON, J. E.Cancer letters. 1995, Vol 90, Num 1, pp 91-96, issn 0304-3835Conference Paper

Biology of mouse mammary tumor virus (MMTV)MATSUZAWA, A; NAKANO, H; YOSHIMOTO, T et al.Cancer letters. 1995, Vol 90, Num 1, pp 3-11, issn 0304-3835Conference Paper

The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cellsCATHERINO, W. H; JORDAN, V. C.Cancer letters. 1995, Vol 90, Num 1, pp 35-42, issn 0304-3835Conference Paper

Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reactionNOGUCHI, S; AIHARA, T; KOYAMA, H et al.Cancer letters. 1995, Vol 90, Num 1, pp 57-63, issn 0304-3835Conference Paper

Primary chemotherapy for early and avanced breast cancerHORTOBAGYI, G. N; BUZDAR, A. U; STROM, E. A et al.Cancer letters. 1995, Vol 90, Num 1, pp 103-109, issn 0304-3835Conference Paper

Tenascin in breast cancer development : is epithelial tenascin a marker for poor prognosis ?YOSHIDA, T; ISHIHARA, A; HIROKAWA, Y et al.Cancer letters. 1995, Vol 90, Num 1, pp 65-73, issn 0304-3835Conference Paper

Heterogeneity of duct carcinoma in situ (DCIS) : Relationship of grade and subtype analysis to local recurrence and risk of invasive transformationLAGIOS, M. D.Cancer letters. 1995, Vol 90, Num 1, pp 97-102, issn 0304-3835Conference Paper